Sapporo Hokuyu Hospital

What Sapporo Hokuyu Hospital does

Founded as a social medical corporation (社会医療法人北楡会), Sapporo Hokuyu Hospital (札幌北楡病院) is a comprehensive general hospital located in Shiroishi-ku, Sapporo, Hokkaido, Japan. It operates three core specialty centers: a Kidney Disease Comprehensive Medical Center integrating nephrology, dialysis (hemodialysis and peritoneal dialysis), vascular access surgery, and kidney transplantation; a Hematology program covering adult and pediatric blood diseases, hematopoietic stem cell transplantation, and CAR-T cell therapy (launched November 2025); and a Digestive Disease Center combined with advanced urology offerings including Da Vinci Xi robotic prostatectomy, TULSA MRI-guided ultrasound ablation, and KOELIS TRINITY MRI fusion prostate biopsy (the first installation in Hokkaido). Additional specialty services include CellEx ECP for graft-versus-host disease, hyperbaric oxygen therapy, UroLift for benign prostatic hyperplasia, and palliative care.

The hospital's technology base is a portfolio of high-capital medical devices and procedure suites rather than a software platform. It generates revenue primarily through insurance-covered medical services billed under Japan's national health insurance reimbursement schedule, supplemented by self-pay fees for television rental (¥250/day), refrigerator rental (¥150/day), patient gown rental (¥100/day), bed linen rental (¥350/day), attendant meals, and medical documentation certificates (¥1,650-¥8,800 per document). All pricing on self-pay services was raised in June 2023 and November 2023 due to input cost pressures. Patients are acquired through outpatient appointments, emergency walk-ins, and inter-facility referrals managed by a dedicated Regional Medical Coordination Office (地域医療連携室). The hospital also operates as a regional referral hub, co-hosting annual Renal Replacement Therapy Seminars with Terumo Corporation and Astellas Pharma, and maintains an academic Elm Clinical Pathology Conference with Hokkaido University.

Its customer base is composed of general insured patients, pediatric and adolescent hematology patients, patients requiring renal replacement therapy or transplantation, and urology patients in Sapporo and broader Hokkaido. The hospital is certified by the Japan Council for Quality Health Care (certification number 4338) and is a designated "Introduction Period Addition 3" facility for artificial kidney treatment. It is privately operated under the social medical corporation structure, headed by Director Junichi Meguro (目黒 順一), with no parent company or external equity ownership disclosed.

Name

Sapporo Hokuyu Hospital

Legal name

Sapporo Hokuyu Hospital (札幌北楡病院)

Website

https://hokuyu-aoth.org

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Sapporo Hokuyu Hospital is a social medical corporation general hospital in Sapporo, Hokkaido, providing integrated kidney disease care, hematology and stem cell transplantation, CAR-T therapy, and advanced urology including robotic surgery, serving insured patients across Hokkaido.

Ownership category

akta.pro rank

Product category

Hospital Healthcare Services

NAICS

General Medical and Surgical Hospitals (62211), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Community & Regional General Hospitals (HLAFAAAB)

akta.pro secondary industries

Transplant Specialty Hospitals (HLAFAHAE), Renal & Dialysis-Integrated LTACHs (HLAFAOAF)

Keywords

• General hospital services
• Kidney disease treatment
• Hematology oncology care
• Urologic surgery
• Dialysis and transplantation

Headquarters

HQ city

Sapporo

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Insurance-Covered Medical Services: The hospital operates as a social medical corporation (社会医療法人) providing comprehensive medical services covered by Japan's national health insurance system. Revenue is generated through consultation fees, procedure fees, hospitalization charges, surgery fees, dialysis treatment fees, and other medical service billings under the national health insurance reimbursement schedule.
2. Self-Pay / Out-of-Pocket Services: Revenue from services not covered by insurance including television and refrigerator rental in patient rooms, patient gowns, bed linens, and meal charges for attendants. Prices were revised upward in June 2023 due to increased electricity and logistics costs.
3. Medical Document Fees: Revenue from issuing medical certificates, hospitalization certificates, diagnosis certificates, and death certificates. Document fees were revised upward in November 2023. Price range: ¥1,650 for clinic diagnosis certificates to ¥8,800 for certificates covering periods of 5+ years or records older than 5 years.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Sapporo Hokuyu Hospital is a regional core general hospital providing comprehensive multi-specialty medical care with distinctive centers for kidney disease (integrating nephrology, hemodialysis, peritoneal dialysis, vascular access surgery, and kidney transplantation), hematology/blood cancer treatment (including hematopoietic stem cell transplantation and CAR-T cell therapy), gastroenterology, urology (robotic surgery, TULSA, MRI fusion biopsy), and vascular surgery. Services are delivered through insurance-covered inpatient and outpatient care, emergency services, and inter-facility patient referrals coordinated by a dedicated Regional Medical Coordination Office.

Product overview

Sapporo Hokuyu Hospital is a comprehensive medical institution offering integrated healthcare services across multiple specialties. The hospital operates a platform-plus-specialized-services model with core departments (internal medicine, surgery, pediatrics) supported by advanced treatment centers. Key products include: robotic surgery (Da Vinci X), MRI-guided TULSA treatment, CAR-T cell therapy for blood cancers, kidney disease comprehensive care (dialysis, peritoneal dialysis, kidney transplantation), hematopoietic stem cell transplantation, ECP therapy for graft-versus-host disease, and specialized diagnostic services (KOELIS TRINITY MRI biopsy, hyperbaric oxygen therapy). The hospital also publishes 'Elm' magazine for public outreach.

Differentiator

Problem solved

Functional benefit

Products and services

• Da Vinci Robotic Surgery (ダ・ヴィンチ手術)
• TULSA Treatment (タルサ治療)
• CAR-T Cell Therapy (CAR-T細胞療法)
• Hematopoietic Stem Cell Transplantation (造血幹細胞移植)
• ECP Treatment (ECP治療)
• Hemodialysis (血液透析)
• Peritoneal Dialysis (腹膜透析)
• Kidney Transplantation (腎臓移植外科)
• KOELIS TRINITY MRI Fusion Prostate Biopsy (KOELIS TRINITY)
• UroLift (ウロリフト)
• Hyperbaric Oxygen Therapy (高気圧酸素治療)
• Apheresis Treatment (アフェレシス)
• Hematology Department (血液内科)
• Pediatric and Adolescent Medicine Department (小児思春期科)
• Orthopedics Department (整形外科)
• Vascular Access Center (バスキュラーアクセスセンター)
• Hospital Magazine 'Elm' (病院広報誌『エルム』)

Quantifiable outcome

• Japan Council for Quality Health Care certified hospital
• +5 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Five partnerships are on record, tiered core, moderate and minor.

• Terumo Corporation (テルモ株式会社)coreStrategic or Co-development Partner · 22 November 2024Terumo Corporation co-hosts the annual Renal Replacement Therapy Seminars with the hospital. The hospital is designated as an Introduction Period Addition 3 (導入期加算３) facility for artificial kidney treatment since fiscal year 2022, with Terumo providing support for related medical education initiatives. Terumo also sponsors the 3rd Renal Replacement Therapy Seminar in November 2024.
• Yumi Memorial Foundation (勇美記念財団)moderateOthers · 22 October 2023The Yumi Memorial Foundation provides sponsorship and support for the 'Hokkaido Blood Disease Patients' Home Life and Medical Care Study Group' (北海道における血液疾患患者の在宅生活と医療を考える会), a medical education initiative on transfusion medicine and home healthcare led by the hospital's Deputy Director Ota.
• Eran Corporation (株式会社エラン)minorImplementation/ SI/ Consulting Partner · 20 March 2023Eran Corporation provides the CS Set (入院セット) service for hospitalized patients, including towel sets and daily necessities on a daily flat-rate basis. The contract is direct between the patient and Eran Corporation; the hospital facilitates the service but is not a party to the commercial arrangement.
• Astellas Pharma Inc. (アステラス製薬株式会社)coreStrategic or Co-development Partner · 26 January 2023Astellas Pharma co-sponsored the Renal Replacement Therapy Seminar (January 2024) with the hospital, which serves as a professional education platform for kidney disease treatment options. The partnership supports medical education and awareness for renal replacement therapy in Hokkaido.
• Hokkaido University Graduate School of Medicine (北海道大学医学院)coreStrategic or Co-development Partner · 17 October 2022Hokkaido University's Department of Tumor Pathology (腫蕵病理学教室) collaborates with the hospital on the annual Elm Clinical Pathology Conference (エルム臨床病理検討会), a medical education conference co-hosted with the hospital. This academic partnership provides continuing medical education for physicians and healthcare professionals in the region.

Scale indicators5 records

Recent moves11 records

Expansion highlights6 records

Broad incumbents

• Hokkaido University Hospital: Premier academic medical center in Hokkaido with full-spectrum specialty care including hematology, transplantation, and robotic surgery. Direct regional competitor for complex cases and physician talent, and academic collaboration partner via the Elm Clinical Pathology Conference.
• Sapporo Medical University Hospital: Major academic hospital in Sapporo offering comprehensive specialty services including advanced hematology, oncology, and surgical specialties. Competes with Sapporo Hokuyu for complex case referrals and physician recruitment in the same metropolitan area.
• Sapporo City General Hospital: Large municipal hospital in Sapporo providing broad specialty coverage including dialysis, oncology, and surgical services. Competes for general patient referrals and provides alternative emergency care capacity in the same metro area.
• Hokkaido Prefectural Central Hospital: Prefectural flagship hospital in Hokkaido providing advanced specialty care including transplantation and oncology. Competes with Sapporo Hokuyu for regional referrals and specialized treatment volumes across the prefecture.

Regional players

• Asahikawa Medical University Hospital: Academic medical center serving northern Hokkaido with comparable multi-specialty capabilities. Competes with Sapporo Hokuyu for kidney disease, hematology, and urology referrals from northern Hokkaido regions where patient transport to Sapporo is feasible.
• Steel Memorial Muroran Hospital: Regional hospital in southern Hokkaido offering general and specialty services including dialysis. Competes for kidney disease and general medical referrals from the broader Hokkaido catchment area served by Sapporo Hokuyu.
• Japanese Red Cross Asahikawa Hospital: Red Cross regional hospital serving central Hokkaido with multi-specialty capabilities. Comparable regional referral hospital competing for complex cases in nephrology, hematology, and surgery across Hokkaido.

Direct peers

• KKR Sapporo Medical Center: Social insurance-affiliated general hospital in Sapporo with comparable multi-specialty service mix including dialysis, oncology, and surgical departments. Closest comparable hospital by ownership structure and service portfolio in the same metro market.
• Teine Keijinkai Hospital: Large private hospital in Sapporo offering comparable general and specialty services including advanced surgery and oncology. Direct competitor for patient referrals across multiple specialties in the Sapporo metropolitan area.
• NTT East Japan Sapporo Hospital: Corporate-affiliated general hospital in Sapporo providing comparable specialty services including dialysis, oncology, and surgery. Competes for outpatient referrals and corporate health program patients in the same metro market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sapporo Hokuyu Hospital